A61K 40/4229
Transforming growth factor [tgf]
Official title: {Transforming growth factor [TGF]}
A61K40/4229 (Transforming growth factor [tgf]) appears on 27 US grants and 76 published applications in this corpus.
Search patents in A61K- Granted patents
- 27
- Published applications
- 76
- Assignees
- 41
- Inventors
- 155
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 2 |
| 2019 | 0 | 5 |
| 2020 | 1 | 7 |
| 2021 | 5 | 10 |
| 2022 | 4 | 9 |
| 2023 | 4 | 12 |
| 2024 | 3 | 8 |
| 2025 | 3 | 8 |
| 2026 | 5 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Transforming growth factor beta-resistant natural killer cells8 Sep 2026US 12,729,228 B2Research Institute At Nationwide Children's Hospital
- Fusion constructs and methods of using thereof11 Aug 2026US 12,703,747 B2Precigen, Inc.
- Engineered T cells31 Mar 2026US 12,590,136 B2Medigene Immunotherapies GmbH
- Bi-specific chimeric antigen receptor31 Mar 2026US 12,590,145 B2The Regents of the University of California
- GPC3 binding molecules3 Feb 2026US 12,540,196 B2Kite Pharma, Inc.
- Methods for enhancing tcrab+ cell depletion efficiency17 Sep 2026US 2026/0274949 A1Allogene Therapeutics, Inc.
- Gpc3 binding molecules20 Aug 2026US 2026/0242507 A1Kite Pharma, Inc.
- Bi-specific chimeric antigen receptor23 Jul 2026US 2026/0209329 A1The Regents of the University of California
- Multi-chain chimeric polypeptides and uses thereof14 May 2026US 2026/0132185 A1HCW Biologics, Inc.
- Methods for enhancing tcrab+ cell depletion efficiency14 May 2026US 2026/0132201 A1Allogene Therapeutics, Inc.
Most cited
By later US patents
- Methods of treating aging-related disorders15US 11,672,826 B2HCW Biologics, Inc. · 2023
- Methods for stimulating proliferation or differentiation of an immune cell with a multi-chain chimeric polypeptide15US 11,730,762 B2HCW Biologics, Inc. · 2023
- Method to prevent graft rejection using TGF-beta to induce T suppressor cells13US 6,759,035 B2University of Southen California · 2004
- TGFBeta signal convertor5US 11,654,158 B22seventy bio, Inc. · 2023
- Prostate-specific membrane antigen cars and methods of use thereof4US 10,780,120 B2The Trustees of the University of Pennsylvania · 2020